Effect of moderate hepatic impairment on the safety and pharmacokinetics of rezafungin

Authors
Category Primary study
JournalCritical Care Medicine
Year 2021
This article has no abstract
Epistemonikos ID: ad20110f1d58b4434f04918932bebb1f46e10904
First added on: Feb 12, 2025